Yale faculty members are translating their research into new technologies and treatments for disease. Yale Ventures helps them along the way.
- January 26, 2023
Yale Cancer Center scientists have developed a novel technology that for the first time enables massively parallel DNA substitutions (known as “knock-ins”) into human cells by leveraging messenger RNA (mRNA), a platform now well-known from its use as the COVID vaccine vehicle.
- January 18, 2023
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2023 Damon Runyon-Rachleff Innovation Award, established to support “high-risk, high-reward” ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer.
- January 11, 2023
Daniel C. DiMaio, MD, PhD, was presented with the Yale Cancer Center Lifetime Achievement Award by Dr. Eric Winer at the Yale Cancer Center Conclave on January 5, 2023.
- December 16, 2022Source: Yale SEAS
Yale researchers have made a discovery that changes conventional thinking about the role that oxygen plays in the growth of tumors—an area of cancer research that has been intensely studied in recent years.
- December 13, 2022Source: Yale News
Yale researchers have uncovered a driver of the chronic inflammation that damages lungs in cystic fibrosis. It could be a target for treatment.
- November 28, 2022Source: American Association for Cancer Research
A CAREER DEVELOPMENT GRANT FROM THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) HELPED YALE CANCER SCIENTIST LUISA ESCOBAR-HOYOS, MSC, PHD, EARN TWO MAJOR, MULTI-YEAR FEDERAL GRANTS TO FURTHER DEVELOP HER RESEARCH.
- November 10, 2022
Giulia Biancon, PhD, has been awarded the 2022 Italian Scientists & Scholars in North America Foundation (ISSNAF) Young Investigator Paola Campese Award.
- October 28, 2022
A team led by Naftali Kaminski, MD, used a newly designed molecule, called MRG-229, with potential therapeutic implications for idiopathic pulmonary fibrosis. The study is one of the first to use a microRNA mimic as a viable therapeutic in the lungs.
- October 17, 2022
Two Yale faculty members, Peter M. Glazer, MD, PhD; and Saad B. Omer, MBBS, MPH, PHD; have been elected to the prestigious National Academy of Medicine, the academy announced today. Founded in 1970 as the Institute of Medicine the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States.